EGFR and thyroid gland carcinoma: In a study, EGCG reduced the levels of phospho (p)-epidermal growth factor receptor (EGFR), H-RAS, p-RAF, p-MEK1/2, and p-ERK1/2 in human thyroid carcinoma cells [18].